The 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013)

10 Top Studies Whose Impact Will Last Well Beyond CROI 2013

CROI 2013 has come and gone, leaving an impressive amount of ground-breaking medical and scientific news in its wake. Josep M. Llibre, M.D., and Benjamin Young, M.D., Ph.D., provide a quick review of the presented research they feel is most likely to have a lingering, real-world impact for health care professionals.

Expert Panel: HIV Drugs in Development, Antiretroviral Strategy and Treatment as Prevention (Video)

Joel Gallant, M.D., and Richard Haubrich, M.D., walk through the latest updates on HIV antiretroviral treatment from CROI 2013. This discussion is moderated by Jeff Berry (pictured), editor of Positively Aware magazine, and produced by the International Foundation for Alternative Research in AIDS.

Functional Cure for HIV-Infected Infant After Very Early Treatment

A 26-month-old infant girl born in Mississippi has been functionally cured of HIV, according to results presented on the first day of CROI 2013. The infant was treated very early (within 31 hours of life) with a full antiretroviral regimen -- a strategy that's markedly different from the standard treatment approach.

More Highlights:

About This Conference

The annual Conference on Retroviruses and Opportunistic Infections (CROI) is one of the most highly regarded, HIV-focused research meetings on the planet. The 2013 incarnation of this conference -- the 20th since the conference's inception in 1994 -- is expected to feature more than 1,100 presentations in dozens of topic areas, and will be attended by more than 4,000 researchers, clinicians and other frontline workers in HIV care, research, prevention, epidemiology and advocacy.

TheBodyPRO.com's coverage of CROI 2013 will include summaries of a wide array of individual studies and presentations, as well as discussions featuring study authors and leading HIV clinicians/researchers.

For more information on CROI 2013, please visit the conference's website. You may also view the conference "pocket program" online.

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

Home

All Headlines

Previous Conferences

No Evidence of Premature Aging Effect in HIV-Positive Patients
Use of Coronary CT Angiography to Detect Early Noncalcified Plaque in Asymptomatic HIV-Positive Patients
Post-Myocardial Infarction Survival in HIV-Positive Patients
Aspirin Use in HIV-Positive Patients
Small Increase in Birth Defects in the French Perinatal Cohort
More >>

TheBodyPRO.com is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. TheBodyPRO.com and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO.com's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.